Case 1: Faricimab in a high-need neovascular nAMD patient

Video

Dr. Khanani shares the case of a neovascular nAMD patient with high disease activity who achieved significant vision improvement and fluid resolution after switching to faricimab.

Sponsored by Roche

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

© 2025 MJH Life Sciences

All rights reserved.